We are live on ! Find out more
AVDL

Avadel Pharmaceuticals
AVDL

Delisted

AVDL was delisted on the 11th of February, 2026.

Back to rankings

89 hedge funds and large institutions have $373M invested in Avadel Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 29 increasing their positions, 29 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more call options, than puts

Call options by funds: $2.85M | Put options by funds: $1.22M

0% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 29

8% less funds holding

Funds holding: 97 → 89 (-8)

25% less capital invested

Capital invested by funds: $500M → $373M (-$127M)

38% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 21

67% less funds holding in top 10

Funds holding in top 10: 6 → 2 (-4)

Holders
89
Holders Change
-8
Holders Change %
-8.25%
% of All Funds
2.33%
Holding in Top 10
2
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-66.67%
% of All Funds
0.05%
New
13
Increased
29
Reduced
29
Closed
21
Calls
$2.85M
Puts
$1.22M
Net Calls
+$1.62M
Net Calls Change
+$1.73M

Top Buyers

Rank Fund Capital Flow
1
Bank of New York Mellon
Bank of New York Mellon
New York
+$12.8M
2
TCM
Tekla Capital Management
Massachusetts
+$7.39M
3
SAM
Senzar Asset Management
New York
+$6.88M
4
Morgan Stanley
Morgan Stanley
New York
+$6.37M
5
FPC
Falcon Point Capital
California
+$5.34M

Top Sellers

Rank Fund Capital Flow
1
KCM
Kennedy Capital Management
Missouri
-$13.9M
2
Jennison Associates
Jennison Associates
New York
-$11.9M
3
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
-$9.91M
4
GTC
Ghost Tree Capital
New York
-$5.71M
5
CPIM
Columbia Partners Investment Management
Virginia
-$3.99M
Name Holding Trade Value Shares
Change 		Change in
Stake
CIP
26
Chartwell Investment Partners
Pennsylvania
$2.8M -$82.3K -5,280 -2%
LOAMU
27
Lombard Odier Asset Management (USA)
New York
$2.69M +$417K +26,753 +14%
Acadian Asset Management
28
Acadian Asset Management
Massachusetts
$2.14M -$1.55M -99,644 -36%
SEI Investments
29
SEI Investments
Pennsylvania
$2.13M +$2.72M +174,380 New
California Public Employees Retirement System
30
California Public Employees Retirement System
California
$2.09M – – –
Ameriprise
31
Ameriprise
Minnesota
$1.91M -$84.2K -5,402 -3%
CS
32
Candriam SCA
Luxembourg
$1.9M +$390K +25,000 +19%
SCM
33
Sio Capital Management
New York
$1.51M -$1.8M -115,681 -48%
D.E. Shaw & Co
34
D.E. Shaw & Co
New York
$1.28M -$916K -58,719 -36%
Janney Montgomery Scott
35
Janney Montgomery Scott
Pennsylvania
$1.24M +$460K +29,500 +41%
DMK
36
David M. Knott
$1.22M +$1.55M +99,587 New
Allianz Asset Management
37
Allianz Asset Management
Germany
$1.13M +$319K +20,475 +36%
KFA
38
Kelleher Financial Advisors
New York
$1M +$1.23M +79,000 +2,633%
CCI
39
Columbus Circle Investors
$896K -$474K -30,420 -29%
CPIM
40
Columbia Partners Investment Management
Virginia
$831K -$3.99M -255,594 -79%
Point72 Asset Management
41
Point72 Asset Management
Connecticut
$818K +$1.04M +67,012 New
GH
42
GAM Holding
Switzerland
$729K – – –
OPPM
43
Opus Point Partners Management
New York
$693K – – –
TSW
44
Thompson Siegel & Walmsley
Virginia
$629K +$270K +17,300 +51%
Comerica Bank
45
Comerica Bank
Texas
$595K -$771K -49,427 -46%
WSA
46
Wall Street Associates
California
$577K -$42.1K -2,700 -5%
Bank of America
47
Bank of America
North Carolina
$502K +$241K +15,454 +60%
PPA
48
Parametric Portfolio Associates
Washington
$498K +$636K +40,792 New
DC
49
Deere & Company
Illinois
$442K +$190K +12,162 +51%
EVM
50
Eaton Vance Management
Massachusetts
$424K – – –
1
2
3 4 5

AVDL Hedge Fund Activity: Q4 2015 in Review

89 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Avadel Pharmaceuticals (AVDL) for Q4 2015, worth a combined $373M — down 25% from $500M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of AVDL and 13 opened new positions — a net loss of 8 holders — while 29 trimmed existing stakes and 29 added.

The largest buyer was Bank of New York Mellon, adding an estimated $12.8M. The largest seller was Kennedy Capital Management, cutting an estimated $13.9M.

  • 89 institutional investors held Avadel Pharmaceuticals (AVDL) as of Q4 2015, down from 97 in Q3 2015.
  • Funds reported $373M of Avadel Pharmaceuticals stock for Q4 2015, down 25% quarter-over-quarter.
  • 13 funds opened new Avadel Pharmaceuticals positions in Q4 2015 and 21 closed out, a net change of -8 holders.
  • The largest Avadel Pharmaceuticals buyer in Q4 2015 was Bank of New York Mellon, an estimated $12.8M added.
  • The largest Avadel Pharmaceuticals seller in Q4 2015 was Kennedy Capital Management, an estimated $13.9M sold.

Based on aggregated 13F filings for Q4 2015.